Fischer Medical Ventures Chan Sing En appointed
Fischer Medical Ventures (BSE: FISCHER) said Chan Sing En has been appointed. The company is valued at about ₹1,738 crore.
What happened
Fischer Medical Ventures (BSE: FISCHER) informed the stock exchanges on 27 October 2026 at 02:53 PM that Chan Sing En has been appointed.
From the filing: "Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company"
Company snapshot
Fischer Medical Ventures is a small-cap company, with a market value of about ₹1,738 crore.
The stock last traded at ₹24.88, against a 52-week range of ₹21.78–₹121.7 (79.6% below the high).
Before this filing the shares had moved −24.5% over the month and −34.4% over three months. Average daily turnover over the last 20 sessions was about ₹3.25 crore.
Promoters held 63.08% at the end of Q2 FY27, up 0.93% points from the previous quarter; 6.81% of promoter shares were pledged. Foreign institutions owned 5.57% and domestic institutions 1.26%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 23 | 5 | 0.77 |
| Q2 FY26 | 86 | — | 2.15 |
| Q3 FY26 | 101 | 19.2 | 0.3 |
| Q4 FY26 | 98 | -7.1 | -0.11 |
| Q1 FY27 | 82 | 3.8 | 0.06 |
What history shows
BCEIE's records show 4 previous management change filings from the company since May 2026.
After those filings, the stock fell 2.1% on average the next trading day and was down 6.1% on average after five days (4 filings with price data).
Market-wide, 4,000 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 3 Sept 2026 | Board Meeting Outcome for Outcome Of Board Meeting | −4.5% | −7.5% |
| 15 Aug 2026 | Resignation of Director/KMP/SMP | −1.3% | −5.6% |
| 15 Aug 2026 | Resignation of Director/KMP/SMP | −1.3% | −5.6% |
| 14 Aug 2026 | Change in Director(s) of the company. | −1.3% | −5.6% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
- Fischer Medical Ventures Ltd Estimates – NSE:FISCHER
- Fischer Medical Ventures appoints Chan Sing En as director of subsidiary
- How Fischer Medical is targeting export-led growth by expanding medical technology pipeline
- Fischer Medical Ventures (FISCHER.NS) Slips 1.53% to ₹29.59, Sitting Midway Between ₹28 Support and ₹31 Resistance - Early Entry Signals
- Fischer Medical Ventures 52 Week Low Streak Extends Again
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.